Brigham and Womens Hospital to back health startups

Four health care technology startups won the opportunity to pilot their products at Brigham and Womens Hospital after wowing experts at the Brigham Innovation Hubs first-ever shark tank competition last night.

Twine Health, a Cambridge-based company that makes software for managing hypertension and other chronic diseases, drew the most interest from the medical sharks. Twine CEO John Moore ultimately chose to team up with Dr. Stuart Pollack, who will test the technology at Brighams Advanced Primary Care Associates.

This is a whole way to access a group of diabetics and hypertensives who are not in control, Pollack told the Herald. Youve got to make it easy (for patients) to interact in a way thats more comfortable for them.

Of the 10 companies competing, four gained new mentors and six failed to impress the sharks. Healo, maker of a mobile product that allows doctors to remotely monitor patient wound care, got a last-minute partner in Pooja Devendran, Brighams executive director of surgical services.

The winning companies didnt receive any funding, but they will be able to test their products with Brigham patients this year. Nathan Ie of Healo called that prize better than money.

The validation is all in the evidence, especially in health care technology, Healo founder Gino Inverso added.

The other contestants to win pilots were MySafeCare, a mobile app for patients to report safety concerns while in the hospital, and Tenacity Health, a peer coaching program to help patients stay healthy.

Weve talked to a lot of people who have great ideas, but what we found is that one of the biggest challenges in moving ideas forward is actually the opportunity to pilot, said Lesley Solomon, strategy and innovation director at Brighams Biomedical Research Institute. What we wanted to do was give startups the opportunity to find a pilot partner Weve committed to piloting in 2014.

See the original post:

Brigham and Womens Hospital to back health startups

Related Posts

Comments are closed.